To visit the old Ventura website, click here.
Ventura Wealth Clients Login here
Refer and earnSupport
logosearch
Create Account
hamburger
home
breadcrumbStocks
breadcrumbAurobindo Pharma Ltd Share Price
breadcrumbValuation

Aurobindo Pharma Ltd Fundamentals

info2
Compare peers arrow

Market Cap

59,744.16 Cr.

Face value

1.00

Book value

576.37

Div. yield

0.000

P/E ratio

17.62

P/B ratio

1.78

Debt/Eq.

0.24

Market Cap

59,744.16 Cr.

Face value

1.00

Book value

576.37

Div. yield

0.00%

P/E ratio

17.62

P/B ratio

1.78

Debt/Eq.

0.24
About Aurobindo Pharma Ltd
arrow

Aurobindo Pharma Limited continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and  Read more ▾

IndustryPharmaceuticals & Drugs
SectorHealthcare
Top subsidiaries
Aurobindo Pharma Produtos Farmaceuticos Limitada
MANAGEMENT
right
Non Executive Independent DirectorSavita Mahajan
Independent DirectorDeepali Pant Joshi
Non Executive Independent DirectorSatakarni Makkapati
Company SecretaryB Adi Reddy
Non Executive Independent DirectorSantanu Mukherjee
left
Non Executive Independent DirectorSavita Mahajan
Independent DirectorDeepali Pant Joshi
Non Executive Independent DirectorSatakarni Makkapati
Company SecretaryB Adi Reddy
Non Executive Independent DirectorSantanu Mukherjee
Non Executive Independent DirectorGirish Vanvari
Non Independent & Non Executive DirectorP Sarath Chandra Reddy
Promoter & Non-Executive DirectorPV Ramprasad Reddy
Vice Chairman & Managing DirectorK Nithyananda Reddy
Whole Time DirectorM Madan Mohan Reddy
ChairmanK Ragunathan
Vice Chairman & Managing DirectorK Nithyananda Reddy
Whole Time DirectorM Sivakumaran
Whole Time DirectorM Madan Mohan Reddy
DirectorP Sarath Chandra Reddy
Promoter & Non-Executive DirectorPV Ramprasad Reddy
Non Executive Independent DirectorAvnit Bimal Singh
Non Executive Independent DirectorSavita Mahajan
Non Executive Independent DirectorGirish Vanvari
Company SecretaryB Adi Reddy
Independent DirectorSantanu Mukherjee
Whole Time DirectorM Madan Mohan Reddy
Non Executive Independent DirectorGirish Paman Vanvari
Non Executive Independent DirectorSantanu Mukherjee
Company Secretary & Compliance OfficerB Adi Reddy
Non Executive Independent DirectorDeepali Pant Joshi
Non Executive Independent DirectorSantanu Mukherjee
Non Executive Independent DirectorSavita Mahajan
Vice Chairman & Managing DirectorK Nithyananda Reddy
Promoter & Non-Executive DirectorPV Ramprasad Reddy
Whole Time DirectorM Madan Mohan Reddy
ChairmanM Ramasubramanian
Vice Chairman & Managing DirectorK Nityananda Reddy
ChairmanMangalam Ramasubramanian Kumar
Non Executive Independent DirectorDeepali Pant Joshi
Non Independent & Non Executive DirectorSatakarni Makkapati
Non Independent & Non Executive DirectorP Sarath Chandra Reddy
Non Independent & Non Executive DirectorSatakarni Makkapati
Promoter & Non-Executive DirectorPV Ramprasad Reddy
Non Independent & Non Executive DirectorP Sarath Chandra Reddy
Non Executive Independent DirectorGirish Vanvari
Company Secretary & Compliance OfficerB Adi Reddy
Other detail of Aurobindo Pharma Ltd
arrow
location
AddressMaitrivihar Complex, Plot No.2, Ameerpet ,Hyderabad ,Telangana-500038.
phone
Telephone040-23736370 / 23747340
email
globe
MORE DETAILS
NSE Code275
NSE SymbolAUROPHARMA
SeriesEQ
ISININE406A01037
Aurobindo Pharma Limited continues to be one of the world’s fastest growing Active Pharmaceutical Ingredients (API) manufacturing companies, driven by cost leadership, flexibility to produce multiple products in the same manufacturing facilities and capabilities in various therapeutic domains. Its API business has ensured the profitability and growth of its formulations business through seamless vertical integration. Its API business is supported by technologically advanced research and development infrastructure, which develops new products and plays a role in the delivery of products to the market. It has built a strong presence in key therapeutic segments such as Central nervous system (CNS), cardiovascular (CVS), anti-retroviral (ARV), anti-diabetics, gastroenterology and antibiotics. Also, it is building a diversified pipeline in high-margin specialty generic formulations segment.
personal

Grow your wealth with more research recommendations

+91